An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
Fiche du document
- doi: 10.1016/j.nicl.2014.11.001
- issn: 2213-1582
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.nicl.2014.11.001
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25429357
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2213-1582
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BA742CE2E62D0
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Knowledge, Classification ofCiter ce document
D. Schmitter et al., « An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease. », Serveur académique Lausannois, ID : 10.1016/j.nicl.2014.11.001
Métriques
Partage / Export
Résumé
Voxel-based morphometry from conventional T1-weighted images has proved effective to quantify Alzheimer's disease (AD) related brain atrophy and to enable fairly accurate automated classification of AD patients, mild cognitive impaired patients (MCI) and elderly controls. Little is known, however, about the classification power of volume-based morphometry, where features of interest consist of a few brain structure volumes (e.g. hippocampi, lobes, ventricles) as opposed to hundreds of thousands of voxel-wise gray matter concentrations. In this work, we experimentally evaluate two distinct volume-based morphometry algorithms (FreeSurfer and an in-house algorithm called MorphoBox) for automatic disease classification on a standardized data set from the Alzheimer's Disease Neuroimaging Initiative. Results indicate that both algorithms achieve classification accuracy comparable to the conventional whole-brain voxel-based morphometry pipeline using SPM for AD vs elderly controls and MCI vs controls, and higher accuracy for classification of AD vs MCI and early vs late AD converters, thereby demonstrating the potential of volume-based morphometry to assist diagnosis of mild cognitive impairment and Alzheimer's disease.